Literature DB >> 10735946

Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin.

B Ahmed1, J J Van Den Oord.   

Abstract

Nitric oxide (NO) is a small molecule produced during the conversion of L-arginine to L-citrulline by NO synthase (NOS). Several isoforms of NOS exist, of which the Ca2+-independent, inducible NOS (iNOS or NOS2) is most prominently expressed by macrophages. iNOS activity and increased levels of iNOS have been found in various tumours and tumour cell lines but not in normal tissues; however, the precise role of NO in tumour progression has yet to be elucidated. We studied the expression of iNOS in paraffin sections of 41 benign naevi and 52 primary malignant melanomas (MM) of the skin, as well as in 13 metastatic MM. In addition, nitrotyrosine, indicative of NO production and formation of peroxynitrite, was studied in frozen sections of 13 naevi and 30 MM. Virtually all naevi expressed iNOS, but very few expressed nitrotyrosine, indicating either that iNOS in naevi is functionally inactive, or that naevus cells lack reactive oxygen radicals and thus do not form peroxynitrite. Normal melanocytes in adjacent uninvolved skin were unreactive for both markers. In MM, iNOS was most frequently expressed in the 'pure' and 'invasive' radial growth phase (RGP), whereas expression in the vertical growth phase (VGP) and metastatic phase occurred only in 76% of cases; moreover, in these latest phases of tumour progression, iNOS staining was weak and focal. We conclude that iNOS is expressed de novo in most benign pigment cell lesions. In MM (iNOS-generated) NO appears to play an important part in the early steps of invasion (i.e. the 'invasive' RGP), where it may stimulate neo-angiogenesis and may be a prerequisite for further tumour progression; this view is also supported by the finding of iNOS in the associated blood vessels in the papillary dermis. Finally, our data suggest that (iNOS-generated) NO plays a less significant part in the VGP and in metastatic melanoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735946     DOI: 10.1046/j.1365-2133.2000.03352.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Stem cell factor affects tumour progression markers in metastatic melanoma cells.

Authors:  Francesca Prignano; Gianni Gerlini; Benedetta Salvatori; Claudio Orlando; Sandra Mazzoli; Nicola Pimpinelli; Silvia Moretti
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

2.  Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

Authors:  Tangying Lu; Rupal Ramakrishnan; Soner Altiok; Je-In Youn; Pingyan Cheng; Esteban Celis; Vladimir Pisarev; Simon Sherman; Michael B Sporn; Dmitry Gabrilovich
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

3.  Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer.

Authors:  Yugang Wu; Lei Yuan; Qicheng Lu; Haiyan Xu; Xiaozhou He
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

4.  Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma.

Authors:  Zhen Yang; Bobbye Misner; Haitao Ji; Thomas L Poulos; Richard B Silverman; Frank L Meyskens; Sun Yang
Journal:  Antioxid Redox Signal       Date:  2013-01-18       Impact factor: 8.401

Review 5.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

Review 6.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

7.  Redox-Related Proteins in Melanoma Progression.

Authors:  Larissa A C Carvalho; Rodrigo G Queijo; Alexandre L B Baccaro; Ádamo D D Siena; Wilson A Silva; Tiago Rodrigues; Silvya Stuchi Maria-Engler
Journal:  Antioxidants (Basel)       Date:  2022-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.